SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
Martin-Richard, M., Díaz Beveridge, R., Arrazubi, V., Alsina, M., Galan Guzmán, M., Custodio, A. B., Gómez, C., Muñoz, F. L., Pazo, R., Rivera, F.
Published in Clinical & translational oncology (01.12.2016)
Published in Clinical & translational oncology (01.12.2016)
Get full text
Journal Article
PP114-MON ARTIFICIAL NUTRITIONAL SUPPORT IN CANCER PATIENTS AFTER ESOPHAGECTOMY: 11 YEARS OF EXPERIENCE
Llop-Talaveron, J, Leiva, E, Farran-Teixidor, L, Badia-Tahull, M, Virgili-Casas, M, Galán-Guzmán, M, Miró-Martin, M, Aranda-Danso, H
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2013)
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2013)
Get full text
Journal Article
O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG
Wagner, A., Grabsch, H., Mauer, M., Lorenzen, S., Bouché, O., Thuss-Patience, P., Elme, A., Moehler, M., Romario, U. Fumagalli, Kang, Y., Folprecht, G., Martens, U., Guzmán, M. Galán, Ducreux, M., García, M. Díez, Piessen, G., Collienne, M., Lordick, F.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
P-153 Safety and effectiveness of sorafenib in elderly patients diagnosed with advanced hepatocellular carcinoma in a monographic oncologic center
Vidales Sepulveda, Z., Gómez Serra, N., Laquente Saez, B., Navarro Pérez, V., Sánchez, C., î Serra Solé, Ruiz Osuna, S., Rota Roca, M., Ramos Rubio, E., Joudanin Seijo, J., Galán Guzmán, M., Leiva, D., Amador Navarrete, A., Lladó, L., Serrano, T., García Guix, M., Martínez Carnicero, L., Mils Julià, K., Iglesias Míguez, C., del Carpio, L., Xiol Quingles, X., Calvo Campos, M.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)
Santasusana, Joan Maurel, García López, José Luis, García, Juan José, Carbonero, Ana Isabel León, Plazas, Javier Gallego, Rovira, Pedro Sánchez, Martos, Carlos Fernández, Guzmán, M Carmen Galán, Jericó, Jesús Florián, Delgado, Francisco Javier Dorta, Espinosa, Javier Casinello, Muñoz, Marta Llanos, Aguilar, Enrique Aranda, Valera, Javier Sastre, García Ribas, Ignacio, Mena, Alfredo Carrato
Published in Clinical & translational oncology (01.12.2005)
Published in Clinical & translational oncology (01.12.2005)
Get full text
Journal Article
Phase II trial of preoperative irinotecan-cisplatin (IC) followed by concurrent IC and radiotherapy (IC/RT) for locally advanced gastric and esophago-gastric junction adenocarcinoma (LA-G/EGJ-A)
Vega-Villegas, M. E., Galán-Guzmán, M. C., Gallego-Plazas, J., Cervantes, A., Escudero, P., Tabernero, J., Massutí, B., Alonso-Orduña, V., Asensio, D., Rivera, F.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article